Agnelli, Giancarlo
University of Perugia
7 papers on CoChat
Most cited papers
- Verified
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
Agnelli, G., Buller, H. R., Cohen, A., Curto, M., Gallus, A. S., Johnson, M., Masiukiewicz, U., Pak, R., Thompson, J., Raskob, G. E., et al. (2013) · New England Journal of Medicine
Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms
Cited by 2,324
- Verified · note
Apixaban for Extended Treatment of Venous Thromboembolism
Agnelli, G., Buller, H. R., Cohen, A., Curto, M., Gallus, A. S., Johnson, M., Porcari, A., Raskob, G. E., & Weitz, J. I. (2013) · New England Journal of Medicine
Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms
Cited by 1,366
- Verified
Antithrombotic Therapy for Venous Thromboembolic Disease
Büller, H. R., Agnelli, G., Hull, R. D., Hyers, T. M., Prins, M. H., & Raskob, G. E. (2004) · Chest
Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms
Cited by 1,249
- Verified
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials
Boutitie, F., Pinede, L., Schulman, S., Agnelli, G., Raskob, G., Julian, J., Hirsh, J., & Kearon, C. (2011) · BMJ
Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms
Cited by 371
- Verified · note
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study
Buller, H. R., Lensing, A. W. A., Prins, M. H., Agnelli, G., Cohen, A., Gallus, A. S., Misselwitz, F., Raskob, G., Schellong, S., & Segers, A. (2008) · Blood
Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms
Cited by 342
- Verified · note
Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939): The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) Study
Agnelli, G., Gallus, A., Goldhaber, S. Z., Haas, S., Huisman, M. V., Hull, R. D., Kakkar, A. K., Misselwitz, F., & Schellong, S. (2007) · Circulation
Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms
Cited by 337
- Verified
Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis: A Randomized Trial
Prandoni, P., Prins, M. H., Lensing, A. W. A., Ghirarduzzi, A., Ageno, W., Imberti, D., Scannapieco, G., Ambrosio, G. B., Pesavento, R., Cuppini, S., et al. (2009) · Annals of Internal Medicine
Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms
Cited by 232
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free